Pieris Pharmaceuticals Announces Public Offering of Common Stock
BOSTON, MA--(Marketwired - February 13, 2018) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other …